Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“The unique code would have made it easier for researchers and the public to track the regulatory histories of specific facilities.”
VerifiedConfidence: HIGH

Reasoning

ProPublica articles describing the Clear Labels Act note that the required unique facility identification number (e.g., a DUNS number) on drug labels would allow researchers and the public to more easily trace drugs to the factories where they were made and to access FDA inspection reports, thereby making it easier to track regulatory histories of specific facilities.

On confidence: Multiple independent excerpts from the same primary source explicitly state that the unique code would have facilitated tracking of regulatory histories.

Important context

The claim refers specifically to the intended effect of the unique code provision in the legislation, not whether the provision was ultimately enacted.

Evidence

Supporting (3)

Limitations

All evidence comes from a single news outlet (ProPublica). No additional independent sources were provided to corroborate the statement.

Last verified:
Sep 27, 2026, 4:24 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate Vote

ProPublica · Naisha Roy